Candor Biotech Limited - Due diligence report

A 360° intelligence report on Candor Biotech Limited: trust score, financial health, credit view, compliance, directors, growth and distress…

2002-07-10 U T, Chandigarh Active Unlisted Active Non-Compliant
Share
CB Candor Biotech Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Candor Biotech Limited — 360° Intelligence Report

Generated from MCA filings & public records
40/100
Trust Score
Caution Indicated

Candor Biotech Limited is assessed as Caution Indicated with a Trust Score of 40/100. Candor Biotech Limited is an active public limited indian non-government company incorporated in 2002, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Candor Biotech Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
40/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
5/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
30/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
50/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Elevated gearing (D/E 1.42).
  • Working-capital cover adequate.

Charges position: 1 open (7.10 Lakh) · 10 satisfied (10.21 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Punjab National Bank8 48.0 cr
State Bank Of India2 48.0 cr
Director Of Industries Himachal Pradesh Through General Manager District Industries Centre1 48.0 cr
Compliance Score: 5/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2015 - filings overdue.
  • Flagged by authority: MCA.
  • Litigation present in 3 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
MANINDER KAUR 01234567 Director 01/04/2018 6 yrs Approved
AMARJIT SINGH 01234567 Director 01/04/2018 6 yrs Approved
SURINDER SINGH 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • MANINDER KAUR has DIN status "Disqualified by RoC u/s 164(2)".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2015 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: AMARJIT SINGH (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 50
Growth signals & trust indicators
Operating for 24+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Statutory filings appear overdue.
Compliance score is weak (5/100).
1 open charge(s) registered - assets are encumbered.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence29/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment26/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 7.10 Lakh already registered.
  • Compliance gaps should be priced into terms.
Investor view36/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
06 Feb 2025
Charge satisfied
Punjab National Bank
14 Jun 2019
Director appointed
SURINDER SINGH (Additional Director)
27 Dec 2018
Director ceased
HARJIT SINGH
30 Sep 2015
Last AGM held
Annual general meeting
09 Sep 2015
Director ceased
MADHU CHAND SINGH
31 Mar 2015
Latest balance sheet
Filed with ROC
10 Jun 2014
Charge created
Punjab National Bank - 30.00 Lakh
17 Jan 2014
Charge created
Punjab National Bank - 20.00 Lakh
11 Jun 2013
Charge created
Punjab National Bank - 20.00 Lakh
30 Nov 2011
Director ceased
UJALJIT SINGH
29 Oct 2010
Charge created
Punjab National Bank - 60.00 Lakh
24 May 2010
Director ceased
HARBIR SINGH WALIA
Director ceased
SUNIL SAWHNEY
07 Aug 2008
Charge created
Director Of Industries Himachal Pradesh Through General Manager District Industries Centre - 7.10 Lakh
29 Sep 2007
Director ceased
YOGESH KUMAR GARG
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
3 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2015 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Satrite Manusec Private Limited U24129PN1989PTC182664 Pune, Maharashtra, India
Appli Coat Services Private Limited U74900DL2009PTC190056 Rohini, Delhi, India
Quester Capsules Private Limited U33111MH2011PTC214098 Nashik, Maharashtra, India
Izenbio U24232TG2011PTC074011 Secunderabad, Telangana, India
Natcopharma U24231TN1994PLC027491 Chennai, Tamil Nadu, India
Sapphire Polyvinyl Private Limited U24134DL2012PTC233964 New Delhi, Delhi, India
Biotropics Pharma Private Limited U74899DL2001PTC109299 Delhi, Delhi, India
Shriya Chemicals Pvt Ltd U24100MH1984PTC032849 Navi Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Candor Biotech Limited before audits and certifications: compliance score 5/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Candor Biotech Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Candor Biotech Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 40/100, distress signals and MSME payment-delay disclosures - know whether Candor Biotech Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Candor Biotech Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Candor Biotech Limited an active company?

Candor Biotech Limited has MCA status “Active” with a compliance score of 5/100 (Caution Indicated).

Is Candor Biotech Limited financially healthy?

Candor Biotech Limited has a Financial Health Score of 30/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Candor Biotech Limited?

Its overall Trust Score is 40/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Candor Biotech Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Candor Biotech Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 10 earlier charge(s) stand satisfied.

Is Candor Biotech Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 5/100 (Caution Indicated).

Is it risky to lend to Candor Biotech Limited?

Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.